Position
Executive Vice President
Company
Nasus Pharma
Tel AvivBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Nasus Pharma Ltd has appointed Eyal Rubin as Executive Vice President and Chief Financial Officer. Mr Rubin brings over two decades of financial leadership experience to the company's executive team.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Vistagen Appoints Nick Tressler as Chief Financial Officer (December 1, 2025)
- Jubilant Pharmova Appoints Daniel J. O’Connor as Chief Executive Officer (December 2, 2025)
- Esperion Appoints John Harlow as Chief Commercial Officer (November 4, 2025)
- Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer (November 4, 2025)
- Kalaris Therapeutics Appoints Matthew Gall as Chief Financial Officer (November 3, 2025)
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
Who to call at Nasus Pharma, and when
A new leader at Nasus Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nasus Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nasus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nasus Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nasus Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nasus Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.